GB1536475A - Influenza vaccine - Google Patents

Influenza vaccine

Info

Publication number
GB1536475A
GB1536475A GB1722/76A GB172276A GB1536475A GB 1536475 A GB1536475 A GB 1536475A GB 1722/76 A GB1722/76 A GB 1722/76A GB 172276 A GB172276 A GB 172276A GB 1536475 A GB1536475 A GB 1536475A
Authority
GB
United Kingdom
Prior art keywords
influenza
jan
types
antigen
influenza vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1722/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/541,512 external-priority patent/US4029763A/en
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of GB1536475A publication Critical patent/GB1536475A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB1722/76A 1975-01-16 1976-01-16 Influenza vaccine Expired GB1536475A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/541,512 US4029763A (en) 1974-08-05 1975-01-16 Influenza vaccine containing purified neuraminidase antigen and method of using the same

Publications (1)

Publication Number Publication Date
GB1536475A true GB1536475A (en) 1978-12-20

Family

ID=24159889

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1722/76A Expired GB1536475A (en) 1975-01-16 1976-01-16 Influenza vaccine

Country Status (7)

Country Link
AU (1) AU507149B2 (enExample)
BE (1) BE837603A (enExample)
CA (1) CA1073355A (enExample)
FR (1) FR2297635A1 (enExample)
GB (1) GB1536475A (enExample)
NL (1) NL7600443A (enExample)
PH (1) PH13837A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (fr) 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins

Also Published As

Publication number Publication date
BE837603A (fr) 1976-05-03
FR2297635B1 (enExample) 1980-06-27
PH13837A (en) 1980-10-16
AU507149B2 (en) 1980-02-07
AU1016376A (en) 1977-07-14
FR2297635A1 (fr) 1976-08-13
NL7600443A (nl) 1976-07-20
CA1073355A (en) 1980-03-11

Similar Documents

Publication Publication Date Title
Ghendon et al. Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines
Wiktor Cell-mediated immunity and postexposure protection from rabies by inactivated vaccines of tissue culture origin
DE3278344D1 (en) Stabilization of influenza virus vaccine
DE69935721D1 (de) Kälte-adaptierte pferde influenza-viren
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
MX9802285A (es) Vacunas y glicoproteinas de virus de parainfluenza.
SE8005824L (sv) Vaccin av hudparvovirus samt forfarande for dess framstellning
BE863676A (fr) Vaccin syncytial du virus respiratoires
WO2001060849A3 (en) Cold-adapted equine influenza viruses
MD20210028A2 (ro) Compoziţie de vaccin combinat, care conţine o doză redusă de poliovirus inactivat, şi procedeu de preparare a acesteia
GB1256456A (en) Ethylethyleneimine as inactivating agent in antigen-containing pharmaceutical preparations
DE69216732D1 (de) Impfstoff gegen den Geflügelanämieerreger
GB1536475A (en) Influenza vaccine
BE880616A (fr) Preparation de vaccin vivant attenue du virus des oeillons
Cox et al. A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models
DK133311C (da) Fremgangsmade til fremstilling af en vaccine til bekempelse af marek's syge indeholdende levende ikke-svekket,celleassocieret virus
AU4930001A (en) Cold-adapted equine influenza viruses
ES2063897T3 (es) Vacuna contra el virus del colera porcino y diagnostico.
ZA891371B (en) Live combination vaccine
FR2385401A1 (fr) Vaccin a virus respiratoire syncytial
GB953992A (en) Vaccine products and method of preparing same
Arnon et al. Anti-influenza synthetic vaccine.
GB1413401A (en) Influenza vaccine
RU2099086C1 (ru) Способ профилактики гриппа у детей живой гриппозной вакциной

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]